Chemomab Therapeutics Ltd
(NAS:CMMB)
$
1.4
0.18 (14.75%)
Market Cap: 20.10 Mil
Enterprise Value: 7.74 Mil
PE Ratio: 0
PB Ratio: 2.01
GF Score: 35/100 Chemomab Therapeutics Ltd (CMMB) Transcripts
- Q1 2023 Chemomab Therapeutics Ltd Earnings Call TranscriptMay 11, 2023$1.62 (-1.52%)Earnings
- Chemomab Therapeutics Ltd at Aegis Virtual Conference TranscriptMay 03, 2023
- Chemomab Therapeutics Ltd at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- Q3 2022 Chemomab Therapeutics Ltd Earnings Call TranscriptNov 11, 2022$2.08Earnings
- Q2 2022 Chemomab Therapeutics Ltd Earnings Call TranscriptAug 12, 2022$4 (+7.24%)Earnings
- Chemomab Therapeutics Ltd at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 Chemomab Therapeutics Ltd Earnings Call TranscriptMay 12, 2022$2.58 (-0.96%)Earnings
- Q4 2021 Chemomab Therapeutics Ltd Earnings Call TranscriptMar 09, 2022$3.79 (+4.41%)Earnings
- 1